Shi Wei - Concepedia

Author

Shi Wei

University of Alabama at Birmingham ORCID

Also Known As

Huifang Zhang, Jaclyn Watkins, Kanekiyo M, Li,, Mark Kilgore, S W Cha, S Wei, S. Wei, SHI WEI, Sai-xue Wei

488

Publications

9.2K

Citations

H-Index

220

Concepts

All Affiliations

University of Alabama at Birmingham Children's Hospital of Fudan University Uppsala University Memorial Sloan Kettering Cancer Center Cornell University

About

Shi Wei is an author at University of Alabama at Birmingham specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	69	3.2K
2	Health Sciences	7	7	286
3	Engineering	6	6	142
4	Natural Sciences	5	5	442
5	Education	1	1	74

Shi Wei

136

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue Aileen I. Fernandez, Matthew Liu, Andrew M. Bellizzi, JAMA Oncology	2022	332
<scp>l</scp> -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer Eun‐Hee Shim, Carolina B. Livi, Dinesh Rakheja, Cancer Discovery	2014	289
Breast Cancer Subtypes Predispose the Site of Distant Metastases Abha Soni, Zhiyong Ren, Omar Hameed, American Journal of Clinical Pathology	2015	270
Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals Ian G. Cowell, Rebecca L. Aucott, Shantha K. Mahadevaiah, Chromosoma Histone ModificationsHistone H3Lysine 9Epigenetic ChangeGenetics	2002	264
Heterochromatin and<i>tri</i>-methylated lysine 20 of histone H4 in animals Niki Kourmouli, Peter Jeppesen, Shantha Mahadevhaiah, Journal of Cell Science	2004	239
Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells Shun Li, Ming Liu, H. Mytrang, Nature Tumor ImmunologyCancer ImmunosurveillanceTh CellsImmunologyTumor Immunity	2020	230
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment Xi Wang, Shusen Wang, Heng Huang, JAMA	2020	215
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer Douglas Yee, Angela DeMichele, Christina Yau, JAMA Oncology	2020	207
Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury Jiping Zhao, Hao Yu, Yudong Liu, American Journal of Physiology-Lung Cellular and Molecular Physiology	2016	192
TGF-β suppresses type 2 immunity to cancer Ming Liu, Fengshen Kuo, Kristelle J. Capistrano, Nature Cancer ImmunosurveillanceImmunologyTumor ImmunityT Cell ImmunityImmunotherapy	2020	182

Page 1